Canada - English - Health Canada

ontario home oxygen and respiratory service inc. - oxygen - gas - 99% - oxygen 99% - other miscellaneous therapeutic agents

Canada - English - Health Canada

glaxosmithkline inc - respiratory syncytial virus prefusion f protein (rsvpref3) - powder for suspension - 120mcg - respiratory syncytial virus prefusion f protein (rsvpref3) 120mcg

United States - English - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride 75 mg - bupropion hydrochloride tablets are indicated for the treatment of major depressive disorder (mdd), as defined by the diagnostic and statistical manual (dsm) . the efficacy of bupropion hydrochloride tablets in the treatment of a major depressive episode was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult subjects with mdd [see clinical studies (14)]. - bupropion hydrochloride tablets are contraindicated in patients with a seizure disorder. - bupropion hydrochloride tablets are contraindicated in patients with a current or prior diagnosis of bulimia or anorexia nervosa as a higher incidence of seizures was observed in such patients treated with bupropion hydrochloride tablets [see warnings and precautions (5.3)]. - bupropion hydrochloride tablets are contraindicated in patients undergoing abrupt discontinuation of alcohol, benzodiazepines, barbiturates, and antiepileptic drugs [see warnings and precautions (5.3) and drug interactions (7.3)].  - th

Canada - English - myHealthbox

ecolab -

United States - English - NLM (National Library of Medicine)

unit dose services - zolpidem tartrate (unii: wy6w63843k) (zolpidem - unii:7k383oqi23) - zolpidem tartrate tablets are indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. zolpidem tartrate tablets have been shown to decrease sleep latency for up to 35 days in controlled clinical studies [see  clinical studies (14) ]. the clinical trials performed in support of efficacy were 4 to 5 weeks in duration with the final formal assessments of sleep latency performed at the end of treatment. zolpidem tartrate tablets are contraindicated in patients with known hypersensitivity to zolpidem. observed reactions include anaphylaxis and angioedema [see warnings and precautions (5.3)] . teratogenic effects: pregnancy category c there are no adequate and well-controlled studies of zolpidem tartrate tablets in pregnant women. studies in children to assess the effects of prenatal exposure to zolpidem have not been conducted; however, cases of severe neonatal respiratory depression have been reported when zolpidem was used at the end of pregnancy, especially whe

Canada - English - Health Canada

apotex inc - methylphenidate hydrochloride - tablet - 10mg - methylphenidate hydrochloride 10mg - respiratory and cns stimulants

Canada - English - Health Canada

apotex inc - methylphenidate hydrochloride - tablet - 20mg - methylphenidate hydrochloride 20mg - respiratory and cns stimulants

Canada - English - Health Canada

apotex inc - methylphenidate hydrochloride - tablet (extended-release) - 20mg - methylphenidate hydrochloride 20mg - respiratory and cns stimulants

Canada - English - Health Canada

apotex inc - methylphenidate hydrochloride - tablet - 5mg - methylphenidate hydrochloride 5mg - respiratory and cns stimulants

Canada - English - Health Canada

apotex inc - sibutramine hydrochloride monohydrate - capsule - 10mg - sibutramine hydrochloride monohydrate 10mg - anorexigenic agents & respiratory and cerebral stimulants, miscellaneous